2026-04-17T06:10:25Zhttps://recercat.cat/oai/requestoai:recercat.cat:2445/1589512025-11-19T20:55:41Zcom_2072_1057col_2072_478917col_2072_478933
RECERCAT
author
de la Torre, Beatriz G.
author
Albericio Palomera, Fernando
2020-05-06T15:36:26Z2020-05-06T15:36:26Z2018-02-272020-05-06T15:36:26Z
This is an analysis from a chemical point of view of the 46 drugs (34 New Chemical Entities and 12 Biologics) approved by the FDA during 2017. The drugs included in the 2017 "harvest" have been classified on the basis of their chemical structure: biologics (antibodies and proteins); peptides; amino acids and natural products; drug combinations; and small molecules.
cc-by (c) de la Torre, Beatriz G. et al., 2018 http://creativecommons.org/licenses/by/3.0/es info:eu-repo/semantics/openAccess
Disseny de medicaments
Pèptids
Farmacologia
Drug design
Peptides
Pharmacology
The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion